Fusion Awarded for Excellent Communication in 2023 Move to New Location
OMAHA, Neb., April 30, 2024 /PRNewswire/ -- Omaha healthcare company Fusion was recognized last week for the company's excellent communication to their internal employees during the move to a new hea
PR NewswireApr 30 08:36 ET
Washington Selects Fusion Health as State-Approved EHR Vendor
Fusion wins contract through competitive procurement WOODBRIDGE, N.J., April 29, 2024 /PRNewswire/ -- Fusion Health, a leading provider of specialized EHR and pharmacy management solutions for correc
PR NewswireApr 29 08:00 ET
Fusion (FUSN) to Report Q1 Earnings: Here's What to Expect
Yahoo FinanceApr 26 09:23 ET
Top 4 Health Care Stocks That May Plunge This Month
As of April 26, 2024, four stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.The RSI is a momentum indicato
BenzingaApr 26 08:09 ET
Fusion Pharmaceuticals: AstraZeneca to Acquire All of Fusion's Shrs at $21 Each in Cash >FUSN
Fusion Pharmaceuticals: AstraZeneca to Acquire All of Fusion's Shrs at $21 Each in Cash >FUSN
Dow JonesApr 25 16:38 ET
Fusion Pharmaceuticals: Ontario Superior Court of Justice Issues Interim Order Regarding AstraZeneca Deal >FUSN
Fusion Pharmaceuticals: Ontario Superior Court of Justice Issues Interim Order Regarding AstraZeneca Deal >FUSN
Dow JonesApr 25 16:37 ET
Express News | Fusion Pharmaceuticals Mails Circular for Special Meeting of Shareholders and Announces Receipt of Interim Order
ReutersApr 25 16:34 ET
Fusion Pharmaceuticals Inc. (FUSN) Ascends But Remains Behind Market: Some Facts to Note
Yahoo FinanceApr 23 18:15 ET
Fusion Pharmaceuticals Inc. (FUSN) Stock Moves -0.09%: What You Should Know
Yahoo FinanceApr 17 18:15 ET
Fusion Pharmaceuticals Cut to Hold From Buy by TD Cowen
Fusion Pharmaceuticals Cut to Hold From Buy by TD Cowen
Dow JonesApr 16 08:03 ET
Express News | Fusion Pharmaceuticals Inc : TD Cowen Cuts to Hold From Buy
Moomoo 24/7Apr 16 01:53 ET
Compete for a new 10-billion-level racetrack! Global pharmaceutical giants grab the beach to lay out the nuclear medicine field
Morgan Stanley estimates that the radiopharmaceuticals market will grow from around $7 billion in 2022 to $39 billion by 2032.
Zhitong FinanceApr 12 09:35 ET
Fusion Pharmaceuticals: Market Perform Rating Amid Acquisition and Promising Prostate Cancer Treatment Data
TipRanksApr 12 01:37 ET
Fusion Pharmaceuticals Inc. (FUSN) Flat As Market Gains: What You Should Know
Yahoo FinanceApr 11 17:50 ET
AstraZeneca Hikes Annual Dividend By 7% Just Before Vote On Its CEO's Pay Package Boost
Thursday, AstraZeneca Plc (NASDAQ:AZN) raised its annualized dividend for 2024 by $0.20 to $3.10 per share, underlining the company's confidence in its performance and cash generation. The company sai
BenzingaApr 11 09:04 ET
Analysts Have Conflicting Sentiments on These Healthcare Companies: Pfizer (PFE) and Fusion Pharmaceuticals (FUSN)
TipRanksApr 10 07:30 ET
Express News | Fusion Pharmaceuticals Hightlights Presentation Of Interim Data From Phase 2 TATCIST Clinical Trial Evaluating FPI-2265 At The AACR Annual Meeting 2024
Moomoo 24/7Apr 9 16:44 ET
Fusion Pharmaceuticals Announces Presentation of Interim Data From the Phase 2 TATCIST Clinical Trial Evaluating FPI-2265 at the AACR Annual Meeting 2024
As of the March 1, 2024 data cutoff, 35 patients received at least one dose of FPI-2265, with 25 patients having at least 12 weeks of follow-up.
Investing.com Apr 9 16:26 ET
Catalyst Watch: Tesla Deliveries, Disney Board Vote, DJT Drama and Fortinet Event
Seeking AlphaMar 28 15:00 ET
What Fusion Pharmaceuticals (NASDAQ:FUSN) Acquisition Means for Investors
TipRanksMar 28 14:49 ET
No Data
No Data